US Stock MarketDetailed Quotes

TCRT Alaunos Therapeutics

Watchlist
  • 2.5800
  • -0.2300-8.19%
Close Nov 29 13:00 ET
  • 2.9399
  • +0.3599+13.95%
Post 17:01 ET
4.13MMarket Cap-349P/E (TTM)

Alaunos Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0.00%4K
1K
-99.83%5K
-90.91%1K
0
4K
0
634.17%2.92M
11K
Operating revenue
--0
0.00%4K
--1K
-99.83%5K
-90.91%1K
--0
--4K
--0
634.17%2.92M
--11K
Cost of revenue
Gross profit
Operating expense
-84.10%1.15M
-85.79%1.17M
-81.98%1.74M
-25.32%28.5M
-60.61%3.36M
-35.27%7.23M
-12.12%8.23M
6.46%9.67M
-50.57%38.16M
-17.25%8.53M
Selling and administrative expenses
-71.86%1.01M
-67.49%990K
-48.96%1.62M
-7.02%12.22M
-16.99%2.43M
9.02%3.58M
-11.20%3.05M
-9.61%3.17M
-52.32%13.14M
39.62%2.93M
-General and administrative expense
-71.86%1.01M
-67.49%990K
----
-7.02%12.22M
-16.99%2.43M
9.02%3.58M
--3.05M
----
-52.32%13.14M
--2.93M
Research and development costs
-96.09%143K
-96.53%180K
-98.06%126K
-34.93%16.28M
-83.36%933K
-53.68%3.66M
-12.65%5.19M
16.56%6.5M
-49.60%25.02M
-31.76%5.61M
Operating profit
84.10%-1.15M
85.83%-1.17M
81.99%-1.74M
19.14%-28.49M
60.57%-3.36M
12.46%-7.23M
12.16%-8.23M
-6.46%-9.67M
54.12%-35.24M
17.36%-8.52M
Net non-operating interest income expense
0
0
0
39.09%-1.92M
0
0
-44.32%-1.07M
-24.89%-853K
-165.26%-3.15M
-19.19%-888K
Non-operating interest expense
--0
--0
--0
-39.09%1.92M
--0
--0
44.32%1.07M
24.89%853K
165.26%3.15M
19.19%888K
Other net income (expense)
101.85%23K
-92.91%37K
-87.42%60K
-813.90%-4.73M
-1,893.20%-4.48M
-588.98%-1.24M
200.00%522K
2,485.00%477K
187.92%662K
133.88%250K
Special income (charges)
--0
--0
----
-4,441.35%-5.77M
---4.59M
---1.43M
84.21%245K
----
117.97%133K
--0
-Less：Restructuring and merger&acquisition
--0
----
----
--1.27M
--850K
--419K
----
----
--0
--0
-Less:Impairment of capital assets
--0
----
----
--4.8M
--3.79M
--1.01M
----
----
--0
--0
-Less:Other special charges
----
----
----
-124.06%-298K
---53K
----
-84.21%-245K
----
---133K
--0
Other non- operating income (expenses)
-87.77%23K
-86.64%37K
-87.42%60K
98.11%1.05M
-57.60%106K
-25.98%188K
575.61%277K
2,485.00%477K
4,169.23%529K
12,400.00%250K
Income before tax
86.70%-1.13M
87.13%-1.13M
83.26%-1.68M
6.86%-35.14M
14.37%-7.84M
4.24%-8.48M
11.67%-8.77M
-2.66%-10.05M
52.09%-37.73M
22.34%-9.16M
Income tax
Net income
86.70%-1.13M
87.13%-1.13M
83.26%-1.68M
6.86%-35.14M
14.37%-7.84M
4.24%-8.48M
11.67%-8.77M
-2.66%-10.05M
52.09%-37.73M
22.34%-9.16M
Net income continuous Operations
86.70%-1.13M
87.13%-1.13M
83.26%-1.68M
6.86%-35.14M
14.37%-7.84M
4.24%-8.48M
11.67%-8.77M
-2.66%-10.05M
52.09%-37.73M
22.34%-9.16M
Minority interest income
Net income attributable to the parent company
86.70%-1.13M
87.13%-1.13M
83.26%-1.68M
6.86%-35.14M
14.37%-7.84M
4.24%-8.48M
11.67%-8.77M
-2.66%-10.05M
52.09%-37.73M
22.34%-9.16M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
86.70%-1.13M
87.13%-1.13M
83.26%-1.68M
6.86%-35.14M
14.37%-7.84M
4.24%-8.48M
11.67%-8.77M
-2.66%-10.05M
52.09%-37.73M
22.34%-9.16M
Basic earnings per share
86.79%-0.7
87.07%-0.71
82.54%-1.1
15.71%-330
18.37%-4.898
11.67%-5.3
26.80%-5.49
16.00%-6.3
-605.41%-391.5
20.00%-6
Diluted earnings per share
86.79%-0.7
87.07%-0.71
82.54%-1.1
15.71%-330
18.37%-4.898
11.67%-5.3
26.80%-5.49
16.00%-6.3
-605.41%-391.5
20.00%-6
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 00.00%4K1K-99.83%5K-90.91%1K04K0634.17%2.92M11K
Operating revenue --00.00%4K--1K-99.83%5K-90.91%1K--0--4K--0634.17%2.92M--11K
Cost of revenue
Gross profit
Operating expense -84.10%1.15M-85.79%1.17M-81.98%1.74M-25.32%28.5M-60.61%3.36M-35.27%7.23M-12.12%8.23M6.46%9.67M-50.57%38.16M-17.25%8.53M
Selling and administrative expenses -71.86%1.01M-67.49%990K-48.96%1.62M-7.02%12.22M-16.99%2.43M9.02%3.58M-11.20%3.05M-9.61%3.17M-52.32%13.14M39.62%2.93M
-General and administrative expense -71.86%1.01M-67.49%990K-----7.02%12.22M-16.99%2.43M9.02%3.58M--3.05M-----52.32%13.14M--2.93M
Research and development costs -96.09%143K-96.53%180K-98.06%126K-34.93%16.28M-83.36%933K-53.68%3.66M-12.65%5.19M16.56%6.5M-49.60%25.02M-31.76%5.61M
Operating profit 84.10%-1.15M85.83%-1.17M81.99%-1.74M19.14%-28.49M60.57%-3.36M12.46%-7.23M12.16%-8.23M-6.46%-9.67M54.12%-35.24M17.36%-8.52M
Net non-operating interest income expense 00039.09%-1.92M00-44.32%-1.07M-24.89%-853K-165.26%-3.15M-19.19%-888K
Non-operating interest expense --0--0--0-39.09%1.92M--0--044.32%1.07M24.89%853K165.26%3.15M19.19%888K
Other net income (expense) 101.85%23K-92.91%37K-87.42%60K-813.90%-4.73M-1,893.20%-4.48M-588.98%-1.24M200.00%522K2,485.00%477K187.92%662K133.88%250K
Special income (charges) --0--0-----4,441.35%-5.77M---4.59M---1.43M84.21%245K----117.97%133K--0
-Less：Restructuring and merger&acquisition --0----------1.27M--850K--419K----------0--0
-Less:Impairment of capital assets --0----------4.8M--3.79M--1.01M----------0--0
-Less:Other special charges -------------124.06%-298K---53K-----84.21%-245K-------133K--0
Other non- operating income (expenses) -87.77%23K-86.64%37K-87.42%60K98.11%1.05M-57.60%106K-25.98%188K575.61%277K2,485.00%477K4,169.23%529K12,400.00%250K
Income before tax 86.70%-1.13M87.13%-1.13M83.26%-1.68M6.86%-35.14M14.37%-7.84M4.24%-8.48M11.67%-8.77M-2.66%-10.05M52.09%-37.73M22.34%-9.16M
Income tax
Net income 86.70%-1.13M87.13%-1.13M83.26%-1.68M6.86%-35.14M14.37%-7.84M4.24%-8.48M11.67%-8.77M-2.66%-10.05M52.09%-37.73M22.34%-9.16M
Net income continuous Operations 86.70%-1.13M87.13%-1.13M83.26%-1.68M6.86%-35.14M14.37%-7.84M4.24%-8.48M11.67%-8.77M-2.66%-10.05M52.09%-37.73M22.34%-9.16M
Minority interest income
Net income attributable to the parent company 86.70%-1.13M87.13%-1.13M83.26%-1.68M6.86%-35.14M14.37%-7.84M4.24%-8.48M11.67%-8.77M-2.66%-10.05M52.09%-37.73M22.34%-9.16M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 86.70%-1.13M87.13%-1.13M83.26%-1.68M6.86%-35.14M14.37%-7.84M4.24%-8.48M11.67%-8.77M-2.66%-10.05M52.09%-37.73M22.34%-9.16M
Basic earnings per share 86.79%-0.787.07%-0.7182.54%-1.115.71%-33018.37%-4.89811.67%-5.326.80%-5.4916.00%-6.3-605.41%-391.520.00%-6
Diluted earnings per share 86.79%-0.787.07%-0.7182.54%-1.115.71%-33018.37%-4.89811.67%-5.326.80%-5.4916.00%-6.3-605.41%-391.520.00%-6
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday-6.28%